What is the difference between CJC-1295 / Ipamorelin Stack and Hexarelin?

CJC-1295 / Ipamorelin Stack: The CJC-1295 (without DAC) and Ipamorelin combination is the most widely researched and community-validated growth hormone secretagogue stack. By pairing a GHRH analog with a selective GHRP, the two peptides act synergistically — producing GH pulses significantly larger than either compound alone, while maintaining a physiological pulse pattern and minimal side effects. Hexarelin: Hexarelin is a potent synthetic hexapeptide GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release via the ghrelin receptor. It produces among the highest GH pulses of any GHRP, but also elevates cortisol and prolactin — a trade-off that distinguishes it from more selective options like Ipamorelin. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take CJC-1295 / Ipamorelin Stack and Hexarelin together?

There is no specific, well-documented interaction rule for combining CJC-1295 / Ipamorelin Stack and Hexarelin in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, CJC-1295 / Ipamorelin Stack or Hexarelin?

CJC-1295 / Ipamorelin Stack is currently fda-approved and Hexarelin is preclinical only. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

CJC-1295 / Ipamorelin Stack vs Hexarelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

CJC-1295 / Ipamorelin Stack

FDA-approved

The CJC-1295 (without DAC) and Ipamorelin combination is the most widely researched and community-validated growth hormone secretagogue stack. By pairing a GHRH analog with a selective GHRP, the two peptides act synergistically — producing GH pulses significantly larger than either compound alone, while maintaining a physiological pulse pattern and minimal side effects.

Full profile

Hexarelin

Preclinical only

Hexarelin is a potent synthetic hexapeptide GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release via the ghrelin receptor. It produces among the highest GH pulses of any GHRP, but also elevates cortisol and prolactin — a trade-off that distinguishes it from more selective options like Ipamorelin.

Full profile

	CJC-1295 / Ipamorelin Stack	Hexarelin
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	CJC-1295 Ipamorelin, Mod GRF 1-29 Ipamorelin, CJC Ipa stack, CJC-1295 without DAC with Ipamorelin, GHRH GHRP combination	Examorelin, EP 23905, MF-6003
Evidence	FDA-approved	Preclinical only
Dosing range	100mcg each–300mcg each mcg, once daily before sleep (or 2–3x daily for more aggressive protocols)	50mcg–200mcg mcg, 1–3x daily (cycling recommended to prevent desensitization)
Administration	Subcutaneous injection (both compounds), Administered together in the same injection	Subcutaneous injection, Intramuscular injection
Key side effects	Water retention (mild, common), Tingling or numbness in hands/feet (transient), Headache (usually first 1–2 weeks), Fatigue or increased sleepiness (often desired at night dose)	Cortisol elevation, Prolactin elevation, Water retention, Increased appetite
Cited sources	2 references	1 reference

Key differences

Evidence level differs: CJC-1295 / Ipamorelin Stack is fda-approved, while Hexarelin is preclinical only.
Administration: CJC-1295 / Ipamorelin Stack — Subcutaneous injection (both compounds), Administered together in the same injection; Hexarelin — Subcutaneous injection, Intramuscular injection.
Frequency: CJC-1295 / Ipamorelin Stack is typically once daily before sleep (or 2–3x daily for more aggressive protocols); Hexarelin is 1–3x daily (cycling recommended to prevent desensitization).
Research depth: this profile cites 2 sources for CJC-1295 / Ipamorelin Stack vs 1 for Hexarelin.

How each works

CJC-1295 / Ipamorelin Stack

CJC-1295 without DAC (Mod GRF 1-29) stimulates GHRH receptors on the pituitary, increasing the amplitude of GH pulses. Ipamorelin independently triggers GH release via the ghrelin receptor (GHS-R1a) with high selectivity — minimal cortisol, prolactin, or aldosterone co-elevation. The combination exploits two separate receptor pathways to produce synergistic GH output. Animal and human studies on each compound individually confirm GH and IGF-1 elevation. The combination is extrapolated from mechanistic research and is the most studied protocol in the peptide research community.

Hexarelin

Hexarelin produces dose-dependent GH release significantly greater than GHRP-6 or Ipamorelin. It also has direct cardioprotective effects via CD36 receptor binding, independent of GH — making it unique among GHRPs. Studies show protection from ischemic cardiac injury and myocardial fibrosis reduction in animal models. Desensitization occurs with chronic continuous use.

Read the full CJC-1295 / Ipamorelin Stack profile Read the full Hexarelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.